TipRanks
Go Ultimate55% OFF

Balaji Amines Limited (BALAMINES) AI Stock Analysis

IN:BALAMINES

Balaji Amines Limited

(NSE:BALAMINES)

Select Model
Rating:68Neutral
Price Target:INR 1,923.00â–²(9.00% Upside)
Action:downgraded
Date:10/07/26

The overall score reflects a financially resilient company with a very strong, low‑leverage balance sheet and reasonable but normalized profitability, offset by recent cash‑flow volatility and an expensive valuation. Technical indicators show the stock in a longer‑term uptrend but with cooling near‑term momentum, leading to a balanced, mid‑range risk‑reward profile rather than a clearly compelling entry point.

Positive Factors
Low Financial LeverageVery low leverage reduces interest and refinancing pressure while preserving financial flexibility. The substantial equity base gives Balaji Amines capacity to support operations, absorb volatility, and fund future investments without relying heavily on additional borrowing.
Negative Factors
Negative Free Cash FlowThe shift to materially negative free cash flow indicates that current reinvestment or working-capital needs are consuming more cash than operations generate after investment. If sustained, this could reduce funding flexibility and weaken the quality of reported earnings.

Balaji Amines Limited (BALAMINES) vs. iShares MSCI India ETF (INDA)

-50%-25%0%25%50%75%100%IN:BALAMINES+26.15%INDA-12.02%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
INR 65.91B
Dividend Yield
0.63%
Average Volume (3M)
16.30K
Price to Earnings (P/E)
27.9
Beta (1Y)
0.95
Revenue Growth
11.08%
EPS Growth
34.10%
Country
India
Employees
1,266
Sector
General
Sector Strength
55
Industry
Chemicals - Specialty

Balaji Amines Limited Business Overview & Revenue Model

Company Description

Balaji Amines Limited, an Indian company, specializes in the production and global distribution of methylamines, ethylamines, their associated derivatives, alongside a diverse portfolio of specialty chemicals and pharmaceutical excipients. The firm's...

How the Company Makes Money

Balaji Amines primarily makes money by manufacturing and selling chemical products—mainly aliphatic amines and amine derivatives—to industrial customers. Its core revenue stream is product sales, where earnings are driven by (a) sales volumes to dome...

Balaji Amines Limited Financial Statement Overview

Summary

Strong, low‑debt balance sheet and solid profitability support resilience, but revenue and margin volatility plus weaker recent cash generation and negative free cash flow temper the strength.

Income Statement

72Positive

Balance Sheet

88Very Positive

Cash Flow

58Neutral
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue15.23B14.25B13.97B16.08B23.38B23.20B
Gross Profit6.07B4.88B4.88B3.50B8.39B8.57B
EBITDA3.52B2.92B2.65B3.53B6.14B6.37B
Net Income2.04B1.67B1.58B2.05B3.26B3.68B
Balance Sheet
Total Assets027.43B22.52B21.46B19.63B18.75B
Cash, Cash Equivalents and Short-Term Investments2.70B2.71B3.50B3.31B3.09B515.37M
Total Debt01.33B110.27M196.97M575.74M1.01B
Total Liabilities-21.52B5.91B2.34B2.53B2.65B5.60B
Stockholders Equity21.52B19.76B18.45B17.22B15.54B12.50B
Cash Flow
Free Cash Flow-1.62B-1.74B874.82M704.14M2.62B842.07M
Operating Cash Flow222.05M1.96B2.73B3.34B3.82B2.32B
Investing Cash Flow-1.15B-3.58B-1.61B-1.64B-1.86B-1.47B
Financing Cash Flow-169.00M865.75M-447.73M-749.66M-812.33M-565.13M

Balaji Amines Limited Technical Analysis

Technical Analysis SentimentNegative
Last Price1764.15

Price Trends

50DMA2156.53Negative
100DMA2160.20Negative
200DMA1713.34Positive

Market Momentum

MACD-97.58Positive
RSI31.80Neutral
STOCH18.49Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:BALAMINES, the sentiment is Negative. The current price of 1764.15 is below the 20-day moving average (MA) of 1985.71, below the 50-day MA of 2156.53, and above the 200-day MA of 1713.34, indicating a neutral trend. The MACD of -97.58 indicates Positive momentum. The RSI at 31.80 is Neutral, neither overbought nor oversold. The STOCH value of 18.49 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:BALAMINES.

Balaji Amines Limited Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

IN:BALAMINES against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
IN:BALAMINESIN:BALAMINES68NeutralINR 57.16B27.90―0.63%11.08%34.10%
IN:AMNPLSTIN:AMNPLST66NeutralINR 7.87B20.29―0.35%-12.40%-3.04%
IN:ALKYLAMINEIN:ALKYLAMINE61NeutralINR 81.33B36.11―0.63%5.11%20.64%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
IN:ANURASIN:ANURAS49NeutralINR 129.99B74.35―0.13%51.77%36.90%
IN:JUBLINGREAIN:JUBLINGREA46NeutralINR 89.05B25.14―0.89%15.41%21.76%
IN:LXCHEMIN:LXCHEM46NeutralINR 42.47B33.72―0.20%5.47%24.88%

* General Sector Average

Performance Comparison

0%50%IN:BALAMINESIN:ALKYLAMINEIN:AMNPLSTIN:ANURASIN:JUBLINGREAIN:LXCHEMDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
IN:BALAMINES and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
IN:BALAMINESBalaji Amines Limited1764.15351.1024.85%
IN:ALKYLAMINEAlkyl Amines Chemicals Limited1590.10-289.30-15.39%
IN:AMNPLSTAmines & Plasticizers Ltd.143.00-70.91-33.15%
IN:ANURASAnupam Rasayan India Ltd.1141.8061.235.67%
IN:JUBLINGREAJubilant Ingrevia Ltd.559.05-127.98-18.63%
IN:LXCHEMLaxmi Organic Industries Ltd.152.80-43.86-22.30%

Balaji Amines Limited Corporate Events

Balaji Amines Sees Bank Loan Credit Rating Withdrawn After Clearing Dues

Sep 12, 2026

Balaji Amines Limited has announced that India Ratings and Research has withdrawn the credit rating assigned to its bank loan facilities after the company obtained No Dues Certificates from all lenders. The withdrawal follows the company’s requ...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 07, 2026